About Contact Us Careers

Cancer Services Market Analysis

Request Free Sample Copy

Report ID: 227
Published Date: Sep 11, 2024
Report Format: PDF, PPT

Buy Now

Cancer Services Market Analysis

The market is segmented by type into blood, breast, ovarian, and others, out of which, the breast segment is anticipated to hold a notable share in the market during the forecast period on account of its higher prevalence across the globe. Breast cancer is the most common type of cancer that occurs frequently in females. A report published by World Health Organization (WHO) in 2020 demonstrated that 2.3 million women across the globe were suffering from breast cancer.

Our in-depth analysis of the global market includes the following segments

By Diagnosis Procedures	Tests PSA CTC Others Imaging Mammography CT Scan Others Endoscopy Colonoscopy Colposcopy Bronchoscopy Biopsy Bone Marrow Needle Biopsy
By Treatment	Vaccines Conjugate Others Growth Blockers Tyrosine Kinase Proteasome Inhibitors
By Type	Blood Breast Ovarian Others
By End-User	Hospitals Specialty Cancer Centers

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Cancer Services Market Size & Share - Growth Trends 2036

Author Credits: Radhika Pawar

Report ID: 227
Published Date: Sep 11, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of cancer, a rising geriatric population, and growing consumption of alcohol, cigarettes, and tobacco are the major factors driving the growth of the cancer services market.

The market is anticipated to attain a CAGR of ~20% over the forecast period, i.e., 2022 - 2031.

The major players in the market are Siemens Healthcare GmbH, Fonar Corporation, Koninklijke Philips N.V., Shimadzu Corporation, Abbott Laboratories, Samsung Medison Co., Ltd., Eli Lilly and Company, Hologic, Inc., Novartis International AG, and GE Group.

Inquiry Before Buying Request Free Sample